Trial Profile
A Phase I Trial to Determine the Impact of Application of Antiperspirant and Deodorant as Well as Washing the Application Site, on the Pharmacokinetics of Testosterone Following Single Dose Applications of 2% Testosterone MD-Lotion (Cutaneous Solution).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Dec 2009
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Acrux DDS
- 10 Oct 2009 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov
- 10 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 10 Mar 2009 New trial record